237 related articles for article (PubMed ID: 38139353)
41. Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway.
Leone A; Roca MS; Ciardiello C; Terranova-Barberio M; Vitagliano C; Ciliberto G; Mancini R; Di Gennaro E; Bruzzese F; Budillon A
Free Radic Biol Med; 2015 Dec; 89():287-99. PubMed ID: 26409771
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases.
Sipos F; Firneisz G; Műzes G
World J Gastroenterol; 2016 Sep; 22(35):7938-50. PubMed ID: 27672289
[TBL] [Abstract][Full Text] [Related]
43. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
44. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
Arif T; Krelin Y; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
[TBL] [Abstract][Full Text] [Related]
45. Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes.
Wu I; Shin SC; Cao Y; Bender IK; Jafari N; Feng G; Lin S; Cidlowski JA; Schleimer RP; Lu NZ
Cell Death Dis; 2013 Jan; 4(1):e453. PubMed ID: 23303127
[TBL] [Abstract][Full Text] [Related]
46. MiRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc.
Saha MN; Abdi J; Yang Y; Chang H
Oncotarget; 2016 Feb; 7(6):7149-60. PubMed ID: 26771839
[TBL] [Abstract][Full Text] [Related]
47. MYC as a regulator of ribosome biogenesis and protein synthesis.
van Riggelen J; Yetil A; Felsher DW
Nat Rev Cancer; 2010 Apr; 10(4):301-9. PubMed ID: 20332779
[TBL] [Abstract][Full Text] [Related]
48. The proto-oncogene c-myc and apoptosis.
Hoffman B; Liebermann DA
Oncogene; 1998 Dec; 17(25):3351-7. PubMed ID: 9916997
[TBL] [Abstract][Full Text] [Related]
49. A conserved element in Myc that negatively regulates its proapoptotic activity.
Herbst A; Hemann MT; Tworkowski KA; Salghetti SE; Lowe SW; Tansey WP
EMBO Rep; 2005 Feb; 6(2):177-83. PubMed ID: 15678160
[TBL] [Abstract][Full Text] [Related]
50. Drosophila Myc: A master regulator of cellular performance.
Grifoni D; Bellosta P
Biochim Biophys Acta; 2015 May; 1849(5):570-81. PubMed ID: 25010747
[TBL] [Abstract][Full Text] [Related]
51. RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.
von Bueren AO; Shalaby T; Oehler-Jänne C; Arnold L; Stearns D; Eberhart CG; Arcaro A; Pruschy M; Grotzer MA
BMC Cancer; 2009 Jan; 9():10. PubMed ID: 19134217
[TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor-β activates c-Myc to promote palatal growth.
Zhu X; Ozturk F; Liu C; Oakley GG; Nawshad A
J Cell Biochem; 2012 Oct; 113(10):3069-85. PubMed ID: 22573578
[TBL] [Abstract][Full Text] [Related]
53. AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo.
Devlin JR; Hannan KM; Ng PY; Bywater MJ; Shortt J; Cullinane C; McArthur GA; Johnstone RW; Hannan RD; Pearson RB
FEBS J; 2013 Nov; 280(21):5307-16. PubMed ID: 23331925
[TBL] [Abstract][Full Text] [Related]
54. Absence of caspase-3 protects pancreatic {beta}-cells from c-Myc-induced apoptosis without leading to tumor formation.
Radziszewska A; Schroer SA; Choi D; Tajmir P; Radulovich N; Ho JC; Wang L; Liadis N; Hakem R; Tsao MS; Penn LZ; Evan GI; Woo M
J Biol Chem; 2009 Apr; 284(16):10947-56. PubMed ID: 19213729
[TBL] [Abstract][Full Text] [Related]
55. Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo.
Morgenbesser SD; Schreiber-Agus N; Bidder M; Mahon KA; Overbeek PA; Horner J; DePinho RA
EMBO J; 1995 Feb; 14(4):743-56. PubMed ID: 7882978
[TBL] [Abstract][Full Text] [Related]
56. Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice.
Wang H; Dolezal JM; Kulkarni S; Lu J; Mandel J; Jackson LE; Alencastro F; Duncan AW; Prochownik EV
J Biol Chem; 2018 Sep; 293(38):14740-14757. PubMed ID: 30087120
[TBL] [Abstract][Full Text] [Related]
57. Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.
Delpuech O; Griffiths B; East P; Essafi A; Lam EW; Burgering B; Downward J; Schulze A
Mol Cell Biol; 2007 Jul; 27(13):4917-30. PubMed ID: 17452451
[TBL] [Abstract][Full Text] [Related]
58. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.
Hann SR; Eisenman RN
Mol Cell Biol; 1984 Nov; 4(11):2486-97. PubMed ID: 6513926
[TBL] [Abstract][Full Text] [Related]
59. [Preparation and characterization of specific antisera directed against different polypeptide domains encoded by the c-myc oncogene for studying the expression of this gene introduced into quail or rat cells].
Ferré F; Martin P; Begue A; Ghysdael J; Saule S; Stéhelin D
C R Acad Sci III; 1986; 303(15):633-6. PubMed ID: 2433006
[TBL] [Abstract][Full Text] [Related]
60. Novel c-MYC target genes mediate differential effects on cell proliferation and migration.
Cappellen D; Schlange T; Bauer M; Maurer F; Hynes NE
EMBO Rep; 2007 Jan; 8(1):70-6. PubMed ID: 17159920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
